Exhibit 99.2

JOINT FILING AGREEMENT

Pursuant to Rule 13d-1(k)(1)(iii) of the Securities Exchange Act of 1934, each of the undersigned agrees that a single joint Schedule 13D and any amendments thereto may be filed on behalf of each of the undersigned with respect to the securities held by each of them in Galectin Therapeutics, Inc.

Date: September 8, 2017	Company Name
	10X FUND, L.P.
		By: 10X Capital Management, LLC, its general partner
	By:	/s/ James C. Czirr
	Name:	James C. Czirr
	Title:	Managing Member
	10X CAPITAL MANAGEMENT, LLC
	By:	/s/ James C. Czirr
	Name:	James C. Czirr
	Title:	Managing Member
	By:	/s/ James C. Czirr
	JAMES C. CZIRR